IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank13
3Y CAGR-49.9%
5Y CAGR-15.4%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-49.9%/yr
vs -23.4%/yr prior
5Y CAGR
-15.4%/yr
Recent deceleration
Acceleration
-26.5pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 6.80% |
| 2024 | 127.53% |
| 2023 | 44.64% |
| 2022 | 53.95% |
| 2021 | 46.50% |
| 2020 | 15.67% |
| 2019 | 8.09% |
| 2018 | 156.37% |
| 2017 | 0.00% |